Herbas VPB

Print
EN | LT
LT - 500 mg dozės fulvestrantas, skirtas išplitusio krūties vėžio gydymui
EN - FULVESTRANT IN A DOSAGE OF 500 MG FOR THE TREATMENT OF ADVANCED BREAST CANCER

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL.: (2013.01) A61K 31/565
A61P 35/00
Patent
(11) Number of the document 5953
(13) Kind of document B
(21) Application number 2012 006
(22) Date of filing the application 2012-01-24
(41) Date of publication of the application 2013-03-25
(45) Date of publication of patent 2013-07-25
PCT application
(86) Number PCT/GB2010/051228
Date 2010-07-26
Priority applications
(30) Number Date Country code
0912999.0 2009-07-27 GB
Applicant
(71) ASTRAZENECA AB,  , S-151 85 Södertälje, SE
Inventors
(72) Isaiah William DIMERY, US
Alan WEBSTER, GB
Grantee
(73) ASTRAZENECA AB,  , S-151 85 Södertälje, SE
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) FULVESTRANT IN A DOSAGE OF 500 MG FOR THE TREATMENT OF ADVANCED BREAST CANCER
Last renewal fee
Payment date Validity (years) Amount
2013-07-19 4 320.00 LTL
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2014-07-26